Results 131 to 140 of about 253,625 (250)

Engineered surface strategies to manage dental implant‐related infections

open access: yesPeriodontology 2000, EarlyView.
Abstract When exposed to the oral environment, dental implants, like natural surfaces, become substrates for microbial adhesion and accumulation, often leading to implant‐related infections—one of the main causes of implant failure. These failures impose significant costs on patients, clinicians, and healthcare systems.
João Gabriel S. Souza   +7 more
wiley   +1 more source

Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - Role of radium-223 [PDF]

open access: yes, 2014
Radium-223 is a first-in-class alpha particle-emitting radiopharmaceutical approved for the treatment of bone metastatic castration-resistant prostate cancer.
El-Dika, Imane H.   +4 more
core   +1 more source

Tudor England and Stewart Scotland Through Spanish Eyes: A Complete Transcription and Translation of Pedro de Ayala's Letter of 1498 to King Ferdinand of Castile and Queen Isabella of Aragon

open access: yesRenaissance Studies, EarlyView.
Abstract Pedro de Ayala served as a diplomat for King Ferdinand II of Aragon and Queen Isabella I of Castile at the courts of Henry VII, King of England, and James IV, King of Scots. In July 1498, he wrote a letter, partly in cipher, to report to his king and queen on such matters as Spain's interests in international diplomacy; the characters and ...
Adrian William Jaime   +2 more
wiley   +1 more source

EFFICACY AND SAFETY OF RADIUM-223 AND STANDARD OF CARE IN PATIENTS WITH BREAST CANCER AND BONE METASTASIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

open access: yesHematology, Transfusion and Cell Therapy
Summary: Radium-223 (Ra-223) has been used to treat metastatic bone disease in prostate cancer, improving overall survival and quality of life. Breast cancer often presents bone metastasis too, but it is often associated with other sites of disease.
Felipe Alves MOURATO   +4 more
doaj   +1 more source

Patient‐reported outcomes in castration‐resistant prostate cancer with bone metastases treated with radium‐223 with or without olaparib

open access: yesCancer, Volume 132, Issue 13, 1 July 2026.
Abstract Background The combination of olaparib plus radium‐223 improved progression‐free survival in patients with metastatic castration‐resistant prostate cancer with bone metastases (BM) in the multicenter, randomized, phase 2 COMRADE trial (NCT03317391). Here, the patient‐reported outcome (PRO) analysis of this trial is reported.
Rana R. McKay   +11 more
wiley   +1 more source

Leveraging machine learning and citizen science data to describe flowering phenology across South Africa

open access: yesPLANTS, PEOPLE, PLANET, Volume 8, Issue 4, Page 1132-1144, July 2026.
Recent shifts in flowering times are an index of, and a response to, human driven climate change. However, most information on these flowering changes is heavily skewed to the northern hemisphere. This imbalance limits our understanding of how climate change is affecting ecosystems, including the mismatches of flowering times between species, increased
Ross D. Stewart   +3 more
wiley   +1 more source

Radium-223 dichloride for the treatment of metastatic prostate cancer

open access: yes, 2014
Introduction: Bone metastases are a frequent complication of many malignancies and are particularly common in metastatic prostate cancer, where they are associated with a high degree of morbidity.
O'Sullivan, Joe; id_orcid   +1 more
core   +1 more source

Feasibility study of radium-223 production in Tehran Research Reactor for treatment of bone metastases [PDF]

open access: yesمجله علوم و فنون هسته‌ای, 2016
Bone metastasis is a major clinical concern that can cause severe pain, bone fractures, spinal cord compression, hypercalcemia and other problems for patients.
Reza Bagheri   +4 more
doaj  

Quantitative single-photon emission computed tomography/computed tomography in assessing the effectiveness of radium-223 dichloride therapy

open access: yesCancer Urology
Background. Systemic radionuclide therapy (RNT) with radium-223 was approved for treatment of bone metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) based on the results of the phase III ALSYMPCA trial.
E. A. Nikolaeva   +6 more
semanticscholar   +1 more source

Comparative Ionomics of Lycopodiaceae and Selaginellaceae Across Diverse Soil Types in Japan

open access: yesEcological Research, Volume 41, Issue 4, July 2026.
We conducted a comparative ionomic analysis of Lycopodiaceae and Selaginellaceae collected from diverse soil types in Japan, including serpentine soils and solfatara fields, to examine how evolutionary lineage and soil environment shape elemental composition in lycophytes.
Akinori Ren   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy